Sarepta Therapeutics, Inc. SRPT Accretion Of Investment Discount Net
Accretion Of Investment Discount Net at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:AccretionOfInvestmentDiscountNet.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s accretion of investment discount net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s accretion of investment discount net?
- Sarepta Therapeutics, Inc. (SRPT) reported accretion of investment discount net of -$530K in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s accretion of investment discount net changed year-over-year?
- Sarepta Therapeutics, Inc.'s accretion of investment discount net increased by 72.3% year-over-year, from -$1.91M to -$530K.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s accretion of investment discount net?
- Over 4 years (2021 to 2025), Sarepta Therapeutics, Inc.'s accretion of investment discount net has grown at a 168.4% compound annual growth rate (CAGR), from -$102K to -$5.29M.
- What does accretion of investment discount net mean?
- Represents the non-cash increase in the carrying value of debt securities held as investments, reflecting the amortization of purchase discounts. This metric adjusts net income to account for the effective interest earned on investment portfolios.